Alex R. Thurman, SVP and Chief Financial Officer of Glaukos Corp (NYSE:GKOS), filed a Form 4 on November 20, 2026, disclosing the exercise of 15,000 stock options and the sale of 13,000 shares of common stock on November 18, 2026, pursuant to a Rule 10b5-1 trading plan.

Key Highlights

  • Option exercise: Thurman exercised 15,000 stock options at an exercise price of $45.71 per share on November 18, 2026.
  • Shares sold: A total of 13,000 shares of common stock were disposed of across 13 separate sale transactions on November 18, 2026, at weighted average prices ranging from $232.65 to $246.12.
  • 10b5-1 plan: Both the option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Thurman on August 18, 2026, covering options set to expire on March 15, 2027.
  • Remaining ownership: Following all reported transactions, Thurman directly held 43,906 shares of common stock, including 5,230 restricted stock units that have not yet vested or been delivered.
  • Expiring options: The exercised stock options carried an expiration date of March 15, 2027, and following the exercise no derivative securities remain beneficially owned, according to the filing.

Thurman's November 18 Option Exercise and Multi-Tranche Share Sales at Glaukos

According to the filing, Thurman first acquired 15,000 shares of Glaukos Corp common stock through the exercise of stock options at $45.71 per share (transaction code M), bringing his reported beneficial ownership to 58,906 shares before any sales. The options exercised were originally granted with a vesting schedule of 25% on the first anniversary of the grant date and the remainder vesting in equal monthly installments over the following three years, with an expiration date of March 15, 2027.

Immediately following the exercise, Thurman sold shares in 13 separate transactions (transaction code S), all on November 18, 2026. The shares were sold in tranches ranging in size from 132 to 3,209 shares, at weighted average prices from $232.65 to $246.12. Each sale transaction was executed across multiple individual trades, and the filing states that full information on the number of shares and prices for each trade is available upon request to the SEC staff, the issuer, or a security holder. The total number of shares disposed of across all 13 sale transactions was 13,000 shares.

The filing notes that all sales were carried out under a Rule 10b5-1 trading plan that Thurman adopted on August 18, 2026. After completion of all transactions, Thurman's direct beneficial ownership stood at 43,906 shares, which the filing states includes 5,230 restricted stock units that have not yet vested or been delivered to him. The Form 4 was signed by Diana Scherer as Attorney-in-Fact and filed on November 20, 2026.

What Was Disclosed

The filing reports that Glaukos Corp SVP and CFO Alex R. Thurman exercised 15,000 stock options at $45.71 and sold 13,000 shares on November 18, 2026, under a 10b5-1 plan, leaving him with direct beneficial ownership of 43,906 shares.